NEW YORK (GenomeWeb) – Becton Dickinson reported today that its fiscal fourth quarter revenues rose 6 percent year over year, driven by strong growth in its medical segment that was partly offset by flat revenue growth in the diagnostics business.  

For the three months ended Sept. 30, the company posted revenues of $3.23 billion compared to $3.06 billion in the year-ago quarter, beating Wall Street analysts' average estimate of $3.22 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.